Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.
Tolcher AW, Mita A, Lewis LD, Garrett CR, Till E, Daud AI, Patnaik A, Papadopoulos K, Takimoto C, Bartels P, Keating A, Antonia S.
Tolcher AW, et al. Among authors: till e.
J Clin Oncol. 2008 Nov 10;26(32):5198-203. doi: 10.1200/JCO.2008.17.2064. Epub 2008 Sep 29.
J Clin Oncol. 2008.
PMID: 18824702
Free PMC article.
Clinical Trial.